Kirby McInerney LLP is investigating potential securities law violations by GE HealthCare Technologies Inc. following the company's Q1 2026 earnings report. GE HealthCare missed earnings estimates with adjusted EPS of $0.99 versus $1.05 expected and lowered its full-year adjusted EPS guidance to $4.80-$5.00 from $4.95-$5.15. The stock dropped about 13% after the announcement, attributed partly to a resolved supplier issue. No lawsuit has been filed yet, but the investigation continues to determine if legal claims can be made under federal securities laws.
Kim Junge Andersen, CFO of ROCKWOOL A/S, vested 6,511 restricted share units on May 22, 2026, as part of the company's 2023 long-term incentive scheme. The shares were granted without a purchase price and traded on Nasdaq Copenhagen. This transaction...
CN Energy Group's subsidiary Pathenbot has signed an order to provide intelligent robotic cargo sorting services in the United States, marking the commercial launch of these services. The initial order covers 100,000 units and includes barcode scanni...
US stock futures gained as investors reacted to positive earnings from companies like Ross Stores, Zoom, and Take-Two Interactive, alongside cautious optimism about US-Iran peace talks. However, uncertainty remains due to Iran's firm stance on uraniu...
BioNTech presented encouraging clinical data for its late-stage cancer drug candidates Pumitamig and Gotistobart at the ASCO 2026 meeting. Pumitamig showed promising anti-tumor activity in a Phase 2/3 study for first-line treatment of non-small cell ...
BioNTech will showcase new clinical data for its late-stage oncology drugs pumitamig and gotistobart at the 2026 ASCO Annual Meeting. Pumitamig showed encouraging anti-tumor activity in first-line non-small cell lung cancer, while gotistobart demonst...
